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Abstract
Background: Ochronosis is connective tissue manifestation of Alkaptonuria. Joint involvement
specially hip and knee destruction is seen. The cartilage is pigmented and destroyed. It is interested
for both pathologists and orthopedic surgeons.
Case Presentation: A 54 years old woman with hip fracture after simple falling is candidate for
surgery, but, after skin and subcutaneous incision over deep fascia there was dark blue
pigmentation which continues toward hip joint. After biopsy of soft tissues and bone, in another
operation, we replace hip joint.
Conclusion: In this case, besides of cartilage destruction of hip joint, there was a lythic lesion of
neck of femur which causes pathologic fracture of hip joint. We planned Total hip replacement
instead of bipolar for her because of cartilage damage of acetabulum.
Background
Ochronosis is the connective tissue manifestation of alka-
ptonuria, a defect in the metabolism of homogentisic acid
(HGA) caused by autosomal recessive mutations of the
HGO gene on chromosome 3q [1].
Homogentisic acid oxidase is responsible for the turnover
of homogentisic acid (HGA) during the course of pheny-
lalanine and tyrosine catabolism [2]. HGA accumulates
and is polymerized into a blue-black pigment that ulti-
mately is deposited in the skin, cartilage, and collagenous
tissues. Specifically, pigment deposition can be seen in
skin, bones, articular cartilages, synovial membranes,
lungs, heart endocardium and valves, and kidneys [3]. The
accumulation eventually causes severe degeneration of
the spine and peripheral joints which may clinically sim-
ulate common arthritic disorders [4]. Alkaptonuria is a
rare disease affecting one in 250,000-1 million people
[5,6].
The most common clinical feature of ochronosis is
ochronotic arthritis[6]. Other common presentations of
ochronosis are:
Darkening of urine with exposure to air or reducing
agents[7].
Thoracolumbar spine disc herniation, porotic vertebral
bodies; osteophyte formation [8,9].
Hip and knee pain are due to cartilage degeneration, and
in the future joint space narrowing, and sclerosis
develop[2,10,11].
Cardiac valve calcification and stenosis, coronary artery
calcifications [3,12-14].
Renal and prostatic stones [1].
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Ruptures of tendons(patellar and Achilles tendons)[6,15].
Ochronosis has a classic triad: 1) degenerative arthritis; 2)
ochronotic pigmentation; and 3) urine that turns black
upon alkalinization. Confirmatory tests for diagnosis are
chromatographic, enzymatic, or spectrophotometric
determinations of HGA.
Currently, symptomatic treatment of the complications of
alkaptonuria is the only option [1]. A symptomatic
approach including treatment of pain, physiotherapy, chi-
ropractic care, and education of the patient for a home
exercise program is the treatment of choice[4].
Alleviation of pain and significant increases in activity has
been achieved with total joint replacement of the hips,
knees, elbows and shoulders[2]. A successful treatment
for tendon ruptures due to ochronosis is primary
repair[6]. High-dose vitamin C decreases urinary benzo-
quinone acetic acid, but has no effect on HGA excretion
and, moreover, no credible studies have shown that treat-
ment with vitamin C is clinically effective. Nitisinone, a
potent inhibitor of 4-hydroxyphenylpyruvate dioxygen-
ase, dramatically reduces production and urinary excre-
tion of homogentisic acid[14]; however, the effectiveness
of Nitisinone in treating ochronosis remains unknown.
Case Presentation
Our case here is related to a 54-year-old Iranian woman
who was referred to emergency room of Sina hospital. She
was feeling pain in her right hip after a simple falling, and
could not bear weight on her leg. The anteroposterior and
lateral radiography of hip joint showed a fracture of neck
of the femur (fig. 1).
Because of a lucency at the base of femur neck, we came to
the conclusion that a pathologic fracture had occurred at
that region. There was no abnormality in laboratory data
of the patient, and she had no other underlying disease
except a chronic low back and hip pain. Roentgenogram
of the spine showed space narrowing and calcification of
the intervertebral discs. The patient had also ochronotic
pigmentation of the sclera (fig. 2).
Thus, before any definite treatment of fractured region, we
decided to take biopsy from the lesion. After incision of
skin and subcutaneous fat, there was a dark blue or even
black lesion in the deep fascia and proximal portion of
tensor fascia lata which had extended to deeper structures
and joint capsule of hip joint (fig. 3).
We took a sample of the black tissue for pathologic exam
and also another sample of the base of greater trochanteric
region, which had a lytic appearance in x-ray of hip. The
result of pathologic exam of these samples had shown
nothing but ochronosis. In another operation, after about
2 weeks, we replaced the fractured hip with cemented hip
prosthesis.
Conclusion
I had never imagined to view such a pigmentation until
we prepared the patient for biopsy. There was a dark blue
or even black material in the deep fascia of the thigh
which extended toward deeper structures of hip joint.
First, I thought it is an injection injury of oil or similar
materials in deep structures of thigh and hip joint. But
after discussing the issue with experts, and regarding their
previous experiences, they suggested that it may be a
metastasis of malignant melanoma. Since ochronosis is
not a malignant disease, heroic resection (wide resection
Anteroposterior x-ray view of pelvis shows right femoral neck fractureFigu e 1
Anteroposterior x-ray view of pelvis shows right fem-
oral neck fracture. X Ray, after falling of patient.
Ochronotic pigmentation of the scleraFigure 2
Ochronotic pigmentation of the sclera. Photography of 
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hip joint from posterior and after capsulotomy of hip,
there was a dark blue pigmentation in the cartilage of fem-
oral head (fig. 4) and acetabulum.
Although she was only 54, we preferred not to preserve
the head for osteosynthesis, because the cartilage of the
femoral head was not healthy, the proximal part of femur
had a lytic lesion, and the head fragment had porosis.
Hence, there remained two other options: 1- bipolar pros-
thesis of hip joint; or, 2- total hip replacement. Because of
the destructive nature of disease on connective tissues and
cartilage of hip joint, the involvement of acetabular carti-
lage, and the probability of sooner destruction, we
decided on a total hip replacement for her. In addition to
lower price of cemented prosthesis, we decided not to use
cementless prosthesis and pressfit constructs, because the
bone quality was not good. At last, we came to this con-
clusion that a cemented total hip joint replacement is the
final treatment for her (fig. 5).
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Dark blue pigmentation of deep tissues and cartilageFigure 3
Dark blue pigmentation of deep tissues and cartilage. 
Photography of operation field and patient tissues, during 
operation.
Head of the femurFigure 4
Head of the femur. Photography of operation field and 
patient tissues, during operation.
Cemented total hip replacement prosthesisFigure 5
Cemented total hip replacement prosthesis. X ray, 
after operation.Page 3 of 4
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